We use cookies necessary to giving you a better online experience. By using our website you consent to all cookies in accordance with our Privacy Policy.
Yes, I accept
ESTRO
Menu
  • Corporate Members
  • E-Library
  • Twitter
  • Linked In
  • Facebook
  • Instagram
  • Join
  • MyESTRO
Search Opener
  • About ESTRO
  • Membership
  • School
  • Workshops
  • Congresses
  • Science
  • Education
  • Advocacy
  • Corporate Members
  • E-Library
  1. Home
  2. About ESTRO
  3. Newsroom
  4. Newsletter
  5. Read it before your patients

Achieve recognition of all radiotherapy professions

Read it before your patients
  • 15/06/2023

    Dose-Escalated Radiotherapy Alone or in Combination With Short-Term Androgen Deprivation for Intermediate-Risk Prostate Cancer: Results of a Phase III Multi-Institutional Trial - Read It Corner

  • 13/06/2023

    Bacterial Decolonization for Prevention of Radiation Dermatitis: A Randomized Clinical Trial - Read It Corner

  • 09/06/2023

    Should organs at risk (OARs) be prioritized over target volume coverage in stereotactic ablative radiotherapy (SABR) for oligometastases? a secondary analysis of the population-based phase II SABR-5 trial - Read It Corner

  • 06/06/2023

    Trifluridine-Tipiracil and Bevacizumab in Refractory Metastatic Colorectal Cancer - Read It Corner

  • 02/06/2023

    Adjuvant chemotherapy following chemoradiotherapy as primary treatment for locally advanced cervical cancer versus chemoradiotherapy alone (OUTBACK): an international, open-label, randomised, phase 3 trial - Read It Corner

  • 25/05/2023

    Proton therapy and limited surgery for paediatric and adolescent patients with craniopharyngioma (RT2CR): a single-arm, phase 2 study - Read It Corner

News Pages: 11 12 13 14 15 16 17 18 19 20
  • Newsletter 2019
  • Newsletter 2018
  • Newsletter 2017

Corner Editor: Philippe Lambin

Submit your article

Corner Editor: Evert van Limbergen

Submit your article
  • Contact
  • Privacy Statement
  • Sitemap
  • Careers
  • FAQ
  • Twitter
  • Linked In
  • Facebook
  • Instagram

© The European SocieTy for Radiotherapy and Oncology. All rights reserved. ESTRO Avenue Marnix 17, 1000 Brussels . +32 477 271 125.